Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome

详细信息    查看全文

• 作者：Dirk J. Blom ; Michael J. Koren ; Eli Roth ; Maria Laura Monsalvo ; C. Stephen Djedjos ; Patric Nelson ; Mary Elliott ; Scott M. Wasserman ; Christie M. Ballantyne and Rury R. Holman
• 刊名：Diabetes, Obesity and Metabolism
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：19
• 期：1
• 页码：98-107
• 全文大小：964K
• ISSN：1463-1326

文摘

To examine the lipid and glycaemic effects of 52 weeks of treatment with evolocumab.